View external media coverage about Appriss to learn what’s happening.
For media inquiries, please visit our inquiries page.
Rite aid recently announced that it is integrating the NarxCare technology platform into its pharmacies to assist pharmacists in identifying substance abuse disorder and making decisions about the dispensing of prescription drugs. Pharmacists…
Appriss Retail made its debut in the RIS News LeaderBoard2020 in a big way, appearing in 22 “Top Ten” categories. The LeaderBoard highlights the solutions retailers prefer in categories such as innovation, ROI, ease…
Michael Davis, CEO and co-founder of Appriss, Inc., was among four business leaders inducted into the Kentucky Entrepreneur Hall of Fame during a ceremony in Lexington, Kentucky, on November 21, 2019. “Entrepreneurs are key drivers of our…
David Speights, Ph.D., chief data scientist for Appriss Retail, sees new operation strategies such as buy-online, pick-up-in-store (BOPIS) and buy-online, return-in-store (BORIS), as an important innovation for brick-and-mortar stores.
Return fraud and abuse has become a costly issue in the cosmetics industry. Appriss Retail’s vice president of marketing, Tom Rittman, spoke with Cosmetics Business about the key challenges beauty retailers face and what they can do to…
Rite Aid is the latest pharmacy chain to utilize Appriss Health’s NarxCare platform to more efficiently identify manage patients at risk for controlled substance abuse and misuse.
The drugstore retailer is applying advanced analytics to identify prescription drug customers at risk for addiction.
Technology company Appriss Health provides prescription drug monitoring analytics to help healthcare organizations improve their management of opioids and avoid misuse.